News

GenDx opens new subsidiary in Baltimore MD

Today, GenDx Products Inc has opened a new subsidiary at the bwtech@UMBC Research and Technology Park South in Baltimore. At the new location order handling, logistics and first line support…

Mucosis Secures €3.7M from Wellcome Trust to Fund Clinical Trials of its Respiratory Syncytial Virus Vaccine in Partnership with Imperial College London Funding will enable new intranasal vaccine SynGEM® to be tested in phase I and IIa human clinical trial

Groningen, the Netherlands, January 20, 2016 – Mucosis B.V., a clinical stage biotechnology company using a proprietary technology platform to develop next-generation and needle-free human vaccines for infectious diseases, today…

Crossbeta and Servier announce strategic alliance

Crossbeta and Servier announce strategic oligomer-based research collaboration in neurological diseases involving misfolded proteins Crossbeta Biosciences and Servier today announced their collaboration in several research projects involving the use of…

Wanted: Entrepreneurs

Are you looking to invest in a company in life sciences with more than just your money? You have come to the right place! Utrecht Holdings is always interested in…

Interview Bram Bout

Recently, EPIRUS Biopharmaceuticals acquired Bioceros, a company in which Utrecht Holdings was a shareholder. Both companies profit from the acquisition, as does society. In the near future, six products, five…